Stay updated with breaking news from வெரோனிக் மைக்கேட். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Press release content from PR Newswire. The AP news staff was not involved in its creation. New Study Predicts Risks of Drug Interactions without Exposing Patients to Harm May 11, 2021 GMT (PRNewsfoto/Tabula Rasa HealthCare) MOORESTOWN, N.J., May 11, 2021 /PRNewswire/ Tabula Rasa HealthCare, Inc. (“TRHC”) (NASDAQ: TRHC), a leading healthcare technology company advancing the safe use of medication, and Regence Health Plans today announced the results of a simulation-based clinical study which demonstrates that TRHC’s MedWise® medication risk score can be used to assess drug safety without exposing real people to actual harm. The study, published online in Clinical and Translational Science, used TRHC’s proprietary MedWise medications safety technology to virtually assess the potential risk of adverse drug events (ADEs) when adding repurposed drugs for COVID-19 treatment to the individual medications of a large-scale population. The results demonstrate ....
It s common for older adults to take multiple medications, whether they re for easing pain, lowering blood pressure or cholesterol or treating a chronic condition. Yet the COVID-19 pandemic has amplified concerns about polypharmacy â regularly taking five or more prescription drugs. Some prescriptions have side effects, such as dizziness, that can be particularly dangerous for older people; others pose a risk of drug interactions. Adding supplements or over-the-counter products to prevent COVID-19, or drugs to treat it, can compound the risks. A few months ago, pharmacist Nicole Brandt counseled a 74-year-old Maryland woman who had come to an outpatient clinic for a wellness checkup. Brandt is executive director of the Peter Lamy Center on Drug Therapy and Aging at the University of Maryland. Her patient had reason to be especially fearful of the pandemic: the woman had advanced kidney disease and was on dialysis. The woman mentioned that she had begun taking high-dos ....